BioSpace News Archive

Press Releases

Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening

October 25, 2024
·
7 min read
Press Releases

GUERBET : Revenue at September 30, 2024.

October 25, 2024
·
7 min read
Press Releases

Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule

October 25, 2024
·
2 min read
Press Releases

EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

October 25, 2024
·
12 min read
Press Releases

Epitopea Closes USD $31 million Pre-Series A Financing

October 25, 2024
·
5 min read
Press Releases

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

October 25, 2024
·
8 min read
Press Releases

Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

October 25, 2024
·
9 min read
Press Releases

Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI

October 25, 2024
·
22 min read
Press Releases

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

October 25, 2024
·
11 min read
Press Releases

Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program

October 25, 2024
·
5 min read